Eli Lilly Bets on GLP-1s to Reclaim Trillion Dollar Value

Eli Lilly, led by CEO Dave Ricks, became the first $1 trillion pharmaceutical company, primarily through its popular weight-loss and diabetes medications. Over 60% of its revenue now depends on these drugs, posing risks related to its reliance on them.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل